Autopsy report · NCT03296085
Bedside Evaluation of Edema
Cause of deathStaffing, sites or logistics
“Principle investigator changed academic affiliation, then later retired. Study terminated after intra-observer validation, but inter-observer validation not completed.”
Life of this trial
- Registered 2 months before it started.
- Ran for about 5 years 1 month before it stopped.
- 1 participant enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Geisinger Clinic
- Sponsor type
- University, hospital or other
- Conditions
- Edema
- Interventions
- Exam for quantity of edema
- Participants
- 1
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
“Principle investigator left the institution” - TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory
“The study principle investigator left the institution.” - Heat-not-burn Tobacco Product to Aid in Switching From Combustible to Noncombustible Nicotine (IQOS)
“Investigator left institution and did not retain the study” - Residual Extensor Lag Approximately 1 Month After Splint or Cast Immobilization of a Mallet Finger
“Due to the investigator leaving the institution, the study was terminated” - Continuous Femoral and Tibial Nerve Blocks in TKA Patients
“Principal Investigator left institution--no subjects completed the study”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.